RK

Rajesh Kumar Jha

Active Director Director DIN 08855098
DIN 08855098 First appointment Aug 2020 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2020
Shareholding value •••• Premium profile

About Rajesh Kumar Jha

Data last updated:

Rajesh Kumar Jha is a Director at Silvom Pharma Private Limited (since 2020). The company operates in Healthcare. Silvom Pharma Private Limited reported revenue of ₹6.7 Lakh (FY 2022).

DIN 08855098
Primary Designation Director
Industry Healthcare
First Appointment 29 Aug 2020
Oldest Company Age 6 yrs
Largest company Silvom Pharma Private Limited · ₹6.7 Lakh (FY 2022)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Silvom Pharma Private Limited U85110MH2020PTC344894
Director29 Aug 20202020₹6.7 Lakh (FY 2022)Active

Board colleagues of Rajesh Kumar Jha

NameDINCompanyDesignation
Ramesh Kumar08790386Silvom Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Silvom Pharma Private Limited
Premium access

Shareholding and investment profile for Rajesh Kumar Jha

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rajesh Kumar Jha

Rajesh Kumar Jha currently holds 1 directorship: Silvom Pharma Private Limited (Director, since 29 Aug 2020, revenue ₹6.7 Lakh (FY 2022)).

Rajesh Kumar Jha was first appointed on 29 Aug 2020 as Director at Silvom Pharma Private Limited.

The current boards of Rajesh Kumar Jha's companies include Ramesh Kumar (Silvom Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available